• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症中的表观遗传学:理解其在内皮功能障碍、免疫抑制中的作用和潜在治疗方法。

Epigenetics in Sepsis: Understanding Its Role in Endothelial Dysfunction, Immunosuppression, and Potential Therapeutics.

机构信息

Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.

出版信息

Front Immunol. 2019 Jun 18;10:1363. doi: 10.3389/fimmu.2019.01363. eCollection 2019.

DOI:10.3389/fimmu.2019.01363
PMID:31275313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6591469/
Abstract

Sepsis has a complex pathophysiology in which both excessive and refractory inflammatory responses are hallmark features. Pro-inflammatory cytokine responses during the early stages are responsible for significant endothelial dysfunction, loss of endothelial integrity, and organ failure. In addition, it is now well-established that a substantial number of sepsis survivors experience ongoing immunological derangement and immunosuppression following a septic episode. The underpinning mechanisms of these phenomena are incompletely understood yet they contribute to a significant proportion of sepsis-associated mortality. Epigenetic mechanisms including DNA methylation, histone modifications, and non-coding RNAs, have an increasingly clear role in modulating inflammatory and other immunological processes. Recent evidence suggests epigenetic mechanisms are extensively perturbed as sepsis progresses, and particularly play a role in endothelial dysfunction and immunosuppression. Whilst therapeutic modulation of the epigenome is still in its infancy, there is substantial evidence from animal models that this approach could reap benefits. In this review, we summarize research elucidating the role of these mechanisms in several aspects of sepsis pathophysiology including tissue injury and immunosuppression. We also evaluate pre-clinical evidence for the use of "epi-therapies" in the treatment of poly-microbial sepsis.

摘要

脓毒症的发病机制复杂,其特征为过度和难治性炎症反应。在早期阶段,促炎细胞因子反应可导致显著的内皮功能障碍、内皮完整性丧失和器官衰竭。此外,现在已经明确,大量脓毒症幸存者在经历一次脓毒症发作后会持续出现免疫功能紊乱和免疫抑制。这些现象的潜在机制尚不完全清楚,但它们导致了相当一部分脓毒症相关的死亡率。表观遗传机制,包括 DNA 甲基化、组蛋白修饰和非编码 RNA,在调节炎症和其他免疫过程中具有越来越明确的作用。最近的证据表明,随着脓毒症的进展,表观遗传机制广泛受到干扰,特别是在血管内皮功能障碍和免疫抑制中发挥作用。尽管治疗性调节表观基因组仍处于起步阶段,但动物模型的大量证据表明,这种方法可能会带来益处。在这篇综述中,我们总结了这些机制在脓毒症病理生理学几个方面的研究进展,包括组织损伤和免疫抑制。我们还评估了“表观遗传学治疗”在治疗多微生物脓毒症中的临床前证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09fd/6591469/950bf9a3a815/fimmu-10-01363-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09fd/6591469/950bf9a3a815/fimmu-10-01363-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09fd/6591469/950bf9a3a815/fimmu-10-01363-g0001.jpg

相似文献

1
Epigenetics in Sepsis: Understanding Its Role in Endothelial Dysfunction, Immunosuppression, and Potential Therapeutics.脓毒症中的表观遗传学:理解其在内皮功能障碍、免疫抑制中的作用和潜在治疗方法。
Front Immunol. 2019 Jun 18;10:1363. doi: 10.3389/fimmu.2019.01363. eCollection 2019.
2
Epigenetic mechanisms of Immune remodeling in sepsis: targeting histone modification.脓毒症免疫重塑的表观遗传机制:针对组蛋白修饰。
Cell Death Dis. 2023 Feb 11;14(2):112. doi: 10.1038/s41419-023-05656-9.
3
Atherosclerosis and flow: roles of epigenetic modulation in vascular endothelium.动脉粥样硬化与血流:血管内皮细胞中表观遗传调控的作用。
J Biomed Sci. 2019 Aug 7;26(1):56. doi: 10.1186/s12929-019-0551-8.
4
Epigenetics of Huntington's Disease.亨廷顿舞蹈症的表观遗传学
Adv Exp Med Biol. 2017;978:277-299. doi: 10.1007/978-3-319-53889-1_15.
5
Epigenetic biomarkers for human sepsis and septic shock: insights from immunosuppression.人类脓毒症和感染性休克的表观遗传生物标志物:免疫抑制的启示。
Epigenomics. 2020 Apr;12(7):617-646. doi: 10.2217/epi-2019-0329. Epub 2020 May 12.
6
Epigenetics of Sepsis.败血症的表观遗传学。
Crit Care Med. 2020 May;48(5):745-756. doi: 10.1097/CCM.0000000000004247.
7
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential.系统性硬化症中表观遗传学的进展:分子机制和治疗潜力。
Nat Rev Rheumatol. 2021 Oct;17(10):596-607. doi: 10.1038/s41584-021-00683-2. Epub 2021 Sep 3.
8
Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension.肺动脉高压潜在表观遗传机制的见解
Braz J Med Biol Res. 2018 Oct 18;51(12):e7437. doi: 10.1590/1414-431X20187437.
9
Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.非编码 RNA 在食管癌表观遗传修饰中的作用。
Biomed Pharmacother. 2019 Sep;117:109192. doi: 10.1016/j.biopha.2019.109192. Epub 2019 Jul 11.
10
Epigenetics in sepsis: targeting histone deacetylases.脓毒症中的表观遗传学:靶向组蛋白去乙酰化酶。
Int J Antimicrob Agents. 2013 Jun;42 Suppl:S8-12. doi: 10.1016/j.ijantimicag.2013.04.004. Epub 2013 May 9.

引用本文的文献

1
The Epigenetics of Sepsis: How Gene Modulation Shapes Outcomes.脓毒症的表观遗传学:基因调控如何影响预后。
Biomedicines. 2025 Aug 8;13(8):1936. doi: 10.3390/biomedicines13081936.
2
Association between the nutritional inflammation index and mortality among patients with sepsis: insights from traditional methods and machine learning-based mortality prediction.脓毒症患者营养炎症指数与死亡率之间的关联:来自传统方法和基于机器学习的死亡率预测的见解
BMC Infect Dis. 2025 Aug 14;25(1):1021. doi: 10.1186/s12879-025-11429-w.
3
TREM2 signaling pathway in sepsis-induced acute lung injury: physiology, pathology, and therapeutic applications.

本文引用的文献

1
Epigenetic regulation of the innate immune response to infection.感染时固有免疫反应的表观遗传调控。
Nat Rev Immunol. 2019 Jul;19(7):417-432. doi: 10.1038/s41577-019-0151-6.
2
Myeloid-Derived Suppressor Cells in Sepsis.脓毒症中的髓源性抑制细胞。
Front Immunol. 2019 Feb 27;10:327. doi: 10.3389/fimmu.2019.00327. eCollection 2019.
3
LPS promotes HBO1 stability via USP25 to modulate inflammatory gene transcription in THP-1 cells.脂多糖通过 USP25 促进 HBO1 稳定性,从而调节 THP-1 细胞中的炎症基因转录。
脓毒症诱导的急性肺损伤中的TREM2信号通路:生理学、病理学及治疗应用
Front Med (Lausanne). 2025 Jun 9;12:1546292. doi: 10.3389/fmed.2025.1546292. eCollection 2025.
4
Research progress on human adenovirus sepsis.人类腺病毒败血症的研究进展
Front Pediatr. 2025 May 19;13:1552958. doi: 10.3389/fped.2025.1552958. eCollection 2025.
5
Molecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative review.脓毒症相关急性肾损伤中DNA甲基化的分子见解及临床意义:一项叙述性综述
BMC Nephrol. 2025 May 22;26(1):253. doi: 10.1186/s12882-025-04179-z.
6
DNA dioxygenase TET2 deficiency aggravates sepsis-induced acute lung injury by targeting ITGA10 via the PI3K/AKT signaling pathway.DNA双加氧酶TET2缺陷通过PI3K/AKT信号通路靶向ITGA10加重脓毒症诱导的急性肺损伤。
Cell Mol Biol Lett. 2025 May 19;30(1):60. doi: 10.1186/s11658-025-00739-1.
7
Interpretable machine learning model for predicting delirium in patients with sepsis: a study based on the MIMIC data.用于预测脓毒症患者谵妄的可解释机器学习模型:基于MIMIC数据的研究
BMC Infect Dis. 2025 Apr 23;25(1):585. doi: 10.1186/s12879-025-10982-8.
8
L-shaped association of body mass index with prognosis in individuals with sepsis: a multicenter cohort study.脓毒症患者体重指数与预后的L型关联:一项多中心队列研究
Diabetol Metab Syndr. 2025 Feb 3;17(1):43. doi: 10.1186/s13098-025-01607-w.
9
The impact of glucose metabolism on inflammatory processes in sepsis-induced acute lung injury.葡萄糖代谢对脓毒症诱导的急性肺损伤炎症过程的影响。
Front Immunol. 2024 Dec 6;15:1508985. doi: 10.3389/fimmu.2024.1508985. eCollection 2024.
10
A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages.多梳组蛋白 EED 表观遗传调控脂多糖耐受巨噬细胞的反应。
Epigenetics Chromatin. 2024 Nov 29;17(1):36. doi: 10.1186/s13072-024-00562-6.
Biochim Biophys Acta Gene Regul Mech. 2018 Sep;1861(9):773-782. doi: 10.1016/j.bbagrm.2018.08.001. Epub 2018 Aug 4.
4
The role of temperature in the detection and diagnosis of neutropenic sepsis in adult solid tumour cancer patients receiving chemotherapy.温度在接受化疗的成年实体瘤癌症患者中性粒细胞减少性脓毒症检测与诊断中的作用
Eur J Oncol Nurs. 2018 Dec;37:12-18. doi: 10.1016/j.ejon.2018.10.001. Epub 2018 Oct 21.
5
The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.降钙素原和 C 反应蛋白或前降钙素单独联合应用可提高新生儿败血症诊断的准确性:一项荟萃分析和系统评价。
Crit Care. 2018 Nov 21;22(1):316. doi: 10.1186/s13054-018-2236-1.
6
Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation.脓毒症和医院感染:患者特征、机制和调节。
Front Immunol. 2018 Oct 23;9:2446. doi: 10.3389/fimmu.2018.02446. eCollection 2018.
7
Recent advances in biosensors for diagnosis and detection of sepsis: A comprehensive review.生物传感器在脓毒症诊断和检测中的最新进展:全面综述。
Biosens Bioelectron. 2019 Jan 15;124-125:205-215. doi: 10.1016/j.bios.2018.10.034. Epub 2018 Oct 19.
8
Combined CD25, CD64, and CD69 biomarker panel for flow cytometry diagnosis of sepsis.流式细胞术检测 CD25、CD64 和 CD69 联合生物标志物panel 对脓毒症的诊断价值。
Talanta. 2019 Jan 1;191:216-221. doi: 10.1016/j.talanta.2018.08.058. Epub 2018 Aug 25.
9
miR-146a Attenuates Sepsis-Induced Myocardial Dysfunction by Suppressing IRAK1 and TRAF6 via Targeting ErbB4 Expression.miR-146a 通过靶向 ErbB4 表达抑制 IRAK1 和 TRAF6 来减轻脓毒症诱导的心肌功能障碍。
Oxid Med Cell Longev. 2018 Aug 27;2018:7163057. doi: 10.1155/2018/7163057. eCollection 2018.
10
Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.慢性危重病与持续性炎症、免疫抑制和分解代谢综合征
Front Immunol. 2018 Jul 2;9:1511. doi: 10.3389/fimmu.2018.01511. eCollection 2018.